Trial Profile
A six week, multicenter, double blind, double-dummy, parallel, comparative study to compare the efficacy, safety and tolerability of ziprasidone with risperidone in the treatment of Chinese subjects with acute exacerbation of schizophrenia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Feb 2021
Price :
$35
*
At a glance
- Drugs Ziprasidone (Primary) ; Risperidone
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Pfizer
- 03 May 2008 Results presented at APA 2008.
- 14 Apr 2008 New trial record.